Monte Rosa Therapeutics Stock Analysis

Monte Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.86. Some equities with similar Price to Book (P/B) outperform the market in the long run. Monte Rosa Therapeutics recorded a loss per share of 1.78. The entity had not issued any dividends in recent years. Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the bodys natural mechanisms to selectively degrade therapeutically relevant proteins. Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is headquartered in Boston, Massachusetts. Monte Rosa operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 93 people. To learn more about Monte Rosa Therapeutics call Markus MD at 617 949 2643 or check out https://www.monterosatx.com.

Monte Rosa Therapeutics Investment Alerts

Monte Rosa Therapeutics Upcoming and Recent Events

Monte Largest EPS Surprises

View All Earnings Estimates

Monte Rosa Environmental, Social, and Governance (ESG) Scores

Monte Stock Institutional Investors

Note, although Monte Rosa's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Monte Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 358.79 M.

Monte Profitablity

Management Efficiency

Monte Rosa Therapeutics has return on total asset (ROA) of (0.2843) % which means that it has lost $0.2843 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6123) %, meaning that it created substantial loss on money invested by shareholders. Monte Rosa's management efficiency ratios could be used to measure how well Monte Rosa manages its routine affairs as well as how well it operates its assets and liabilities. As of February 25, 2025, Return On Tangible Assets is expected to decline to -0.42. In addition to that, Return On Capital Employed is expected to decline to -0.53. At present, Monte Rosa's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.17, whereas Other Current Assets are forecasted to decline to about 3.6 M.

Technical Drivers

As of the 25th of February, Monte Rosa secures the Mean Deviation of 3.79, standard deviation of 4.99, and Risk Adjusted Performance of (0.04). Monte Rosa Therapeutics technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Monte Rosa Therapeutics variance and value at risk to decide if Monte Rosa Therapeutics is priced some-what accurately, providing market reflects its recent price of 5.78 per share. Given that Monte Rosa Therapeutics has information ratio of (0.06), we recommend you to check Monte Rosa's last-minute market performance to make sure the company can sustain itself at a future point.

Monte Rosa Therapeutics Price Movement Analysis

Monte Rosa Therapeutics Insider Trading Activities

Monte Rosa Outstanding Bonds

Monte Rosa Predictive Daily Indicators

Monte Rosa Corporate Filings

Monte Rosa Forecast Models

Monte Rosa's time-series forecasting models are one of many Monte Rosa's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Monte Rosa's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Monte Rosa prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Monte shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Monte Rosa. By using and applying Monte Stock analysis, traders can create a robust methodology for identifying Monte entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Monte analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Monte analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Monte Rosa Therapeutics stock analysis indicators help investors evaluate how Monte Rosa stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Monte Rosa shares will generate the highest return on investment. By understating and applying Monte Rosa stock analysis, traders can identify Monte Rosa position entry and exit signals to maximize returns.

When running Monte Rosa's price analysis, check to measure Monte Rosa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Monte Rosa is operating at the current time. Most of Monte Rosa's value examination focuses on studying past and present price action to predict the probability of Monte Rosa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Monte Rosa's price. Additionally, you may evaluate how the addition of Monte Rosa to your portfolios can decrease your overall portfolio volatility.